PRIMARY MEMBRANOUS NEPHROPATHY
Clinical trials for PRIMARY MEMBRANOUS NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEMBRANOUS NEPHROPATHY trials appear
Sign up with your email to follow new studies for PRIMARY MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug zanubrutinib takes on kidney disease in major trial
Disease control OngoingThis study tests whether the drug zanubrutinib can help people with primary membranous nephropathy, a kidney disease that causes protein leakage. About 178 participants will receive either zanubrutinib or the standard drug tacrolimus. The goal is to see if zanubrutinib reduces pr…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE2, PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kidney patients: drug may stop protein leak without lifelong pills
Disease control OngoingThis study tests a drug called obinutuzumab against a standard treatment (tacrolimus) in 142 adults with primary membranous nephropathy, a kidney disease that lets protein leak into urine. The goal is to see if obinutuzumab can bring about complete remission (no protein in urine)…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Kidney drug trial pulled before it even started
Disease control TerminatedThis was a planned study to compare a newer drug, obinutuzumab, against a standard treatment (steroids plus cyclophosphamide) for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The goal was to see which treatment worked better and had fe…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New antibody drug aims to tackle kidney disease
Disease control OngoingThis study tests a new drug, zuberitamab, in 135 adults with primary membranous nephropathy, a kidney condition that causes protein leakage. Participants receive either zuberitamab (two doses two weeks apart) or the standard drug cyclosporine. The main goal is to see if zuberitam…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug shows promise for tough kidney diseases
Disease control OngoingThis study tests a new drug called povetacicept in adults with certain autoimmune kidney diseases, including lupus nephritis and IgA nephropathy. The goal is to see if the drug is safe and can help control the disease. Participants receive the drug every 4 weeks for at least 6 mo…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Alpine Immune Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Which kidney test is more accurate? new study aims to find out
Knowledge-focused OngoingThis observational study compares two common blood tests—creatinine and cystatin C—to see which one better estimates actual kidney function in people with nephrotic syndrome. Researchers will use stored blood samples from 50 participants in three ongoing clinical trials. The goal…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:33 UTC